Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study of Pembrolizumab and Lenvatinib for Patients with Advanced Vulvar Cancer Not Suitable for Surgery or Radiotherapy
GermanyStudy on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy
BelgiumStudy on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response
The NetherlandsStudy of Arfolitixorin, 5-Fluorouracil, Oxaliplatin, and Bevacizumab for Patients with Metastatic Colorectal Cancer
GermanyStudy on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination
ItalyStudy of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
BulgariaStudy of Dostarlimab for Patients with Untreated Stage III Resectable Colon Cancer
BelgiumStudy on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease
FranceStudy on Fluorescence-Guided Surgery Using cRGD-ZW800-1 for Patients with Laryngeal and Hypopharyngeal Cancer
The NetherlandsStudy of DNAJB1-PRKACA Peptide Vaccine for Patients with Fibrolamellar Hepatocellular Carcinoma and Other Tumors with Oncogenic Driver Fusion
GermanyStudy of Atezolizumab, Carboplatin, and Nab-Paclitaxel for Patients with Metastatic Triple-Negative PD-L1 Positive Breast Cancer
ItalyStudy on the Effectiveness of Adding Progesterone to Chemotherapy with Etoposide, Doxorubicin, Cisplatin, and Mitotane for Advanced Adrenocortical Carcinoma Patients
ItalyThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
